Clinical trials
Phase 4 Kidney Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 5 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
| Asan Medical Center | 1 |
| Case Comprehensive Cancer Center | 1 |
| Centre Francois Baclesse | 1 |
| Chad R. Tracy | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Fox Chase Cancer Center | 1 |
| Kidney Cancer Research Bureau | 1 |
| Lisa Sanderson Cox, PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 21 |
| Carcinoma, Renal Cell | 9 |
| Liver Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Lung Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Colonic Neoplasms | 2 |
Trials
Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.